About
Obalon Therapeutics is a medical technology company based in San Diego, California. The company specializes in developing and commercializing gastric balloon technology aimed at facilitating weight loss for obese and overweight individuals. With a strong engineering focus, Obalon collaborates with leading clinicians to create high-quality medical products that address chronic diseases related to obesity. The flagship product, the Obalon Balloon System, is a swallowable, gas-filled gastric balloon designed to be placed in the stomach. This system helps patients feel full and reduces food intake, promoting weight loss as part of a comprehensive weight management program. Obalon primarily targets healthcare providers and clinics in the United States that specialize in obesity treatment, ensuring a focused approach to its market. In 2021, Obalon Therapeutics was acquired by ReShape Lifesciences Inc., which may enhance its product development and market reach in the future.
Technologies
Keywords
Company Information
-
Employees 2
-
Founded 2008
-
Annual Revenue $1588000
-
Total Funding $115430047
Location
5421 Avenida Encinas, Carlsbad, California, United States, 92008